This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …

Patients with hematologic malignancy and hematopoietic cell transplant (HCT) recipients
are at increased risk for invasive fungal infection (IFI) as a result of immunosuppression or …

Background Little is known about the morbidity and mortality of invasive fungal disease (IFD)
at a population level. The aim of this study was to determine the incidence, trends and …

Invasive fungal infections (IFIs) is an important complication for acute myeloid leukemia
(AML) patients receiving induction chemotherapy. However, the epidemiological information …

Background Invasive fungal disease (IFD) causes morbidity and mortality in patients with
hematological malignancy. Recurrence of IFD after chemotherapy or hematopoietic stem …

BACKGROUND: Invasive fungal infections (IFI) are one type of representing total infections
in compromised patients. To analyze the characteristics and to determine the prognostic …

Introduction: Invasive fungal infection (IFI) is a major cause of morbidity and mortality in
allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. A previous history …

Objectives Invasive fungal disease (IFD) remains a major concern in patients with
haematological conditions. We describe diagnoses, therapeutic management and outcomes …

Background Invasive fungal disease (IFD) is an important problem complicating the therapy
of haematologic patients. Aim This study aimed to provide data on the epidemiology of IFD …

Simple Summary Invasive fungal infections (IFD) are a significant cause of morbidity and
mortality in patients with hematological malignant disorders. The aim of this retrospective …